Toshima Z. Parris

2.1k total citations
84 papers, 1.5k citations indexed

About

Toshima Z. Parris is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Toshima Z. Parris has authored 84 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 32 papers in Cancer Research and 26 papers in Oncology. Recurrent topics in Toshima Z. Parris's work include Effects of Radiation Exposure (12 papers), Breast Cancer Treatment Studies (12 papers) and Cancer Genomics and Diagnostics (11 papers). Toshima Z. Parris is often cited by papers focused on Effects of Radiation Exposure (12 papers), Breast Cancer Treatment Studies (12 papers) and Cancer Genomics and Diagnostics (11 papers). Toshima Z. Parris collaborates with scholars based in Sweden, United States and Jordan. Toshima Z. Parris's co-authors include Khalil Helou, Per Karlsson, Anikó Kovács, Eva Forssell‐Aronsson, Szilárd Nemes, Nils-Petter Rudqvist, Emil Schüler, Shahin Hajizadeh, Britta Langen and Zakaria Einbeigi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Toshima Z. Parris

77 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Toshima Z. Parris Sweden	20	778	381	379	274	272	84	1.5k
William H. St. Clair United States	24	1.0k 1.3×	487 1.3×	307 0.8×	260 0.9×	565 2.1×	60	2.1k
Qian Hao China	25	1.0k 1.3×	412 1.1×	623 1.6×	144 0.5×	515 1.9×	89	2.1k
Khaled Aziz United States	19	738 0.9×	225 0.6×	411 1.1×	121 0.4×	200 0.7×	40	1.3k
Yanping Sun China	21	824 1.1×	235 0.6×	476 1.3×	234 0.9×	401 1.5×	45	1.8k
Woo Chul Noh South Korea	22	467 0.6×	479 1.3×	516 1.4×	204 0.7×	227 0.8×	89	1.3k
George P. Amorino United States	20	778 1.0×	289 0.8×	517 1.4×	265 1.0×	388 1.4×	27	1.6k
Guanjun Wang China	24	835 1.1×	367 1.0×	310 0.8×	201 0.7×	148 0.5×	51	1.6k
Zhimin Shao China	19	506 0.7×	449 1.2×	409 1.1×	189 0.7×	138 0.5×	96	1.3k
Yusheng Wang China	24	813 1.0×	228 0.6×	263 0.7×	247 0.9×	223 0.8×	138	1.8k
Cuizhi Geng China	24	689 0.9×	579 1.5×	579 1.5×	141 0.5×	310 1.1×	133	1.6k

Countries citing papers authored by Toshima Z. Parris

Since Specialization

Citations

This map shows the geographic impact of Toshima Z. Parris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshima Z. Parris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshima Z. Parris more than expected).

Fields of papers citing papers by Toshima Z. Parris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshima Z. Parris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshima Z. Parris. The network helps show where Toshima Z. Parris may publish in the future.

Co-authorship network of co-authors of Toshima Z. Parris

This figure shows the co-authorship network connecting the top 25 collaborators of Toshima Z. Parris. A scholar is included among the top collaborators of Toshima Z. Parris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshima Z. Parris. Toshima Z. Parris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kovács, Anikó, Leif Klint, Barbro Linderholm, & Toshima Z. Parris. (2025). Changes in HER2low and HER2-ultralow status in 47 advanced breast carcinoma core biopsies, matching surgical specimens, and their distant metastases assessed by conventional light microscopy, digital pathology, and artificial intelligence. Breast Cancer Research and Treatment. 213(3). 397–408. 1 indexed citations

Kovács, Anikó, et al.. (2025). The prognostic value of changes in Ki67 following neoadjuvant chemotherapy in residual triple-negative breast cancer: a Swedish nationwide registry-based study. Breast Cancer Research and Treatment. 210(3). 719–736. 1 indexed citations

Rönnerman, Elisabeth Werner, Pernilla Dahm‐Kähler, Per Karlsson, et al.. (2025). Unveiling histotype-specific biomarkers in ovarian carcinoma using proteomics. PubMed. 33(3). 201019–201019. 1 indexed citations

Larsson, Peter, Alexandra Abramsson, Henrik Zetterberg, et al.. (2024). Repurposing proteasome inhibitors for improved treatment of triple-negative breast cancer. Cell Death Discovery. 10(1). 57–57. 11 indexed citations

Larsson, Peter, Maria Cristina De Rosa, Benedetta Righino, et al.. (2024). Integrated transcriptomics- and structure-based drug repositioning identifies drugs with proteasome inhibitor properties. Scientific Reports. 14(1). 18772–18772. 1 indexed citations

Parris, Toshima Z., Salmir Nasic, M. Sundquist, et al.. (2023). Clinical evaluation of molecular surrogate subtypes in patients with ipsilateral multifocal primary breast cancer. Breast Cancer Research. 25(1). 36–36. 2 indexed citations

Rönnerman, Elisabeth Werner, Szilárd Nemes, Pernilla Dahm‐Kähler, et al.. (2023). Trefoil factor family proteins as potential diagnostic markers for mucinous invasive ovarian carcinoma. Frontiers in Oncology. 12. 1112152–1112152. 3 indexed citations

Parris, Toshima Z., M. Sundquist, Per Karlsson, et al.. (2023). Clinical relevance of biomarker discordance between primary breast cancers and synchronous axillary lymph node metastases. Clinical & Experimental Metastasis. 40(4). 299–308. 3 indexed citations

Zhang, Chenyang, Anikó Kovács, Toshima Z. Parris, et al.. (2020). Adjuvant chemotherapy and survival in women aged 70 years and older with triple-negative breast cancer: a Swedish population-based propensity score-matched analysis. The Lancet Healthy Longevity. 1(3). e117–e124. 20 indexed citations

10.

Engqvist, Hanna, Toshima Z. Parris, Anikó Kovács, et al.. (2020). Validation of Novel Prognostic Biomarkers for Early-Stage Clear-Cell, Endometrioid and Mucinous Ovarian Carcinomas Using Immunohistochemistry. Frontiers in Oncology. 10. 162–162. 28 indexed citations

11.

Hultborn, Ragnar, et al.. (2020). Male Breast Carcinoma after Irradiation and Long-Term Phenothiazine Exposure: A Case Report. Case Reports in Oncology. 13(2). 956–961.

12.

Parris, Toshima Z., Khalil Helou, Elisabeth Kenne Sarenmalm, et al.. (2020). Previously diagnosed multiple primary malignancies in patients with breast carcinoma in Western Sweden between 2007 and 2018. Breast Cancer Research and Treatment. 184(1). 221–228. 10 indexed citations

13.

Engqvist, Hanna, Toshima Z. Parris, Jana Biermann, et al.. (2020). Integrative genomics approach identifies molecular features associated with early-stage ovarian carcinoma histotypes. Scientific Reports. 10(1). 7946–7946. 16 indexed citations

14.

Biermann, Jana, Szilárd Nemes, Toshima Z. Parris, et al.. (2019). A 17-marker panel for global genomic instability in breast cancer. Genomics. 112(2). 1151–1161. 9 indexed citations

15.

Engqvist, Hanna, Toshima Z. Parris, Elisabeth Werner Rönnerman, et al.. (2018). Transcriptomic and genomic profiling of early-stage ovarian carcinomas associated with histotype and overall survival. Oncotarget. 9(80). 35162–35180. 12 indexed citations

16.

Langen, Britta, Nils-Petter Rudqvist, Toshima Z. Parris, et al.. (2015). Transcriptional response in normal mouse tissues after i.v. 211At administration - response related to absorbed dose, dose rate, and time. EJNMMI Research. 5(1). 1–1. 60 indexed citations

17.

Parris, Toshima Z., Anikó Kovács, Shahin Hajizadeh, et al.. (2014). Clinical relevance of breast cancer-related genes as potential biomarkers for oral squamous cell carcinoma. BMC Cancer. 14(1). 324–324. 35 indexed citations

18.

Rudqvist, Nils-Petter, Toshima Z. Parris, Emil Schüler, Khalil Helou, & Eva Forssell‐Aronsson. (2012). Transcriptional response of BALB/c mouse thyroids following in vivo astatine-211 exposure reveals distinct gene expression profiles. EJNMMI Research. 2(1). 32–32. 31 indexed citations

19.

Kovács, Anikó, Kristina Lövgren, Szilárd Nemes, et al.. (2010). Up-regulation of cell cycle arrest protein BTG2 correlates with increased overall survival in breast cancer, as detected by immunohistochemistry using tissue microarray. BMC Cancer. 10(1). 296–296. 30 indexed citations

20.

Parris, Toshima Z., Anna Danielsson, Szilárd Nemes, et al.. (2010). Clinical Implications of Gene Dosage and Gene Expression Patterns in Diploid Breast Carcinoma. Clinical Cancer Research. 16(15). 3860–3874. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact